Author Credentials
Specialist Anaesthetist
Founder, Periop Concepts
FANZCA, MBBS (hons), BMedSci, PGCertCT
Abstract
There is a new wave of aspiration risk heading towards our operating theatres in the coming years. The popular weight loss drugs, glucagon-like peptide (GLP-1) receptor agonists, are providing us with new dilemmas in fasting guidelines and airway management. What does the anaesthetic team need to know?
Recommended Citation
Madden, Jack D. FANZCA and Goyen, Andrew K.
(2024)
"The new era of aspiration risk: The dilemma of GLP-1 receptor agonists,"
Journal of Perioperative Nursing: Vol. 37
:
Iss.
1
, Article 5.
Available at: https://doi.org/10.26550/2209-1092.1291
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
